CCND2 and breast carcinoma: However, silencing of cyclin D2 expression by promoter methylation is also associated with cancer progression in breast cancer [21-23], lung [23], pancreatic [24] and gastric cancer [25], suggesting that cyclin D2 might act as a tumor suppressor gene in a cancer-type dependent manner.